|
⚲
|
| Keyboard |
| Salzman Amber
✚
|
|
|---|---|
| CIK # | 0001674536 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001674536] | |
| 4 | [0001674536] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Salzman Amber | |
| Akcea Therapeutics Inc | |
| Adverum Biotechnologies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-10-12 | Disposed to issuer | 26,400 | $2.01 | 53,064 |
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-10-12 | Disposed to issuer | 53,000 | $0.21 | 11,130 |
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-04-13 | Grant | 26,400 | $0.00 | |
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-02-12 | Grant | 53,000 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2018-02-15 | Grant | 478,000 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2017-02-09 | Grant | 378,000 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Common Stock
|
2017-02-09 | Grant | 262,000 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Common Stock
|
2016-05-11 | Grant | 629,766 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2016-05-11 | Grant | 377,890 | $0.00 | |
|
Adverum Biotechnologies Inc ADVM
Stock Option (Right to Buy) · derivative
|
2016-05-11 | Grant | 218,000 | $0.00 |